HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 28 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $11,000 | -47.6% | 17,890 | +326.0% | 0.00% | – |
| Q3 2018 | $21,000 | -65.6% | 4,200 | -77.7% | 0.00% | – |
| Q2 2018 | $61,000 | – | 18,800 | +9300.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 200 | -90.5% | 0.00% | – |
| Q4 2017 | $4,000 | +100.0% | 2,100 | +75.0% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 1,200 | +140.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 500 | +400.0% | 0.00% | – |
| Q1 2017 | $0 | – | 100 | -52.4% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 210 | -99.2% | 0.00% | – |
| Q3 2016 | $57,000 | -6.6% | 25,412 | +13.0% | 0.00% | – |
| Q2 2016 | $61,000 | +408.3% | 22,496 | +399.9% | 0.00% | – |
| Q1 2016 | $12,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,280,185 | $9,755,000 | 1.01% |
| Cormorant Asset Management, LP | 201,000 | $1,532,000 | 0.24% |
| PUTNAM INVESTMENTS LLC | 575,692 | $4,386,000 | 0.01% |
| Alyeska Investment Group, L.P. | 114,113 | $870,000 | 0.01% |
| VANGUARD GROUP INC | 4,355,424 | $131,473,000 | 0.01% |
| BLACKROCK ADVISORS LLC | 463,200 | $3,530,000 | 0.00% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 26,100 | $199,000,000 | 0.00% |
| Ironwood Financial, llc | 870 | $7,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 24,293 | $185,000 | 0.00% |
| Sonora Investment Management, LLC | 500 | $3,000 | 0.00% |